Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 938-445-6 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (non-LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2012 - 2013
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 012
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 406 (Skin Sensitisation)
- Deviations:
- no
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- EU Method B.6 (Skin Sensitisation)
- Deviations:
- no
- Principles of method if other than guideline:
- Not applicable
- GLP compliance:
- yes (incl. QA statement)
- Type of study:
- guinea pig maximisation test
- Justification for non-LLNA method:
- It is acknowledged by the registrant that the LLNA has advantages over the GPMT in terms of animal welfare, time need, objectivity of read out and quantitation of results, however, unspecific findings of substance known to be non-sensitizers are published in peer-reviewed scentific literature and cannot be excluded in the LLNA, especially for unsaturated organic substances (see reference literature). For this group of chemicals, the GPMT may give results that more adequately reflect the relevance in humans. (reference literature: Comparison of the skin sensitizing potential of unsaturated compounds asassessed by the murine local lymphnode assay(LLNA)and the guinea pig maximization test(GPMT), Food and Chemical Toxicology 46 (2008) 1896–1904).
Due to the fact that the registered substance contains unsaturated organic components, it was considered justified to conduct a GPMT.
Test material
- Reference substance name:
- Alcohols, C16-18 (even numbered, C18-unsatd.), ethoxylated, and alcohols C20-22 (even numbered), sulfates, ammonium salts
- EC Number:
- 938-445-6
- Molecular formula:
- C16H37NO4S - C34H72NO12S
- IUPAC Name:
- Alcohols, C16-18 (even numbered, C18-unsatd.), ethoxylated, and alcohols C20-22 (even numbered), sulfates, ammonium salts
- Test material form:
- solid: compact
- Details on test material:
- - Name of test material (as cited in study report): DE07_2012_001_PLSW
- Physical state: solid
- Lot/Batch No. PU20740016, PU20740019
- Expiration date of lot/batch: 14/03/2014
- Storage condition of test materilal: common room light, room temperature
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): DE07_2012_001_PLSW
- Substance type: Alkylsulfate/alkylethersulfate
- Chemical name: Alcohols, C16-18 (even numbered, C18-unsatd.), ethoxylated, and alcohols C20-22 (even numbered), sulfates, ammonium salts
- CAS: n/a
- Physical state: ivory paste-like solid at 20 °C
- Batch No.: PU20740016, PU20740019
- Purity: 100 % (UVCB)
- Storage condition of test material: Room temperature, protected from light
- Stability: stable under test conditions
In vivo test system
Test animals
- Species:
- guinea pig
- Strain:
- other: Crl: HA - Guinea Pigs
- Sex:
- female
- Details on test animals and environmental conditions:
- Species/strain: healthy Crl: HA - Guinea Pigs (full barrier)
Source: Charles River, 97633 Sulzfeld, Germany
Sex: female (non-pregnant, nulliparous)
Age at the
beginning of the study: 4 weeks old
Body weight at the
beginning of the study: 324 - 369 g
Housing and Feeding Conditions
- Semi barrier in an air-conditioned room
- Temperature: 22 +/- 3 °C
- Relative humidity: 55 +/- 10 %
- Artificial light, sequence being 12 hours light, 12 hours dark
- Air change: at least 10 x / hour
- Free access to autoclaved hay and to Altromin 3122 maintenance diet for guinea pigs, rich in crude fibre
- Free access to tap water (drinking water, municipal residue control, microbiological controls at regular intervals)
- The animals were kept in groups in Terluran - cages on Altromin saw fibre bedding
- Certificates of food, water and bedding are filed
- Adequate acclimatisation period (at least five days) under laboratory conditions
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- intradermal and epicutaneous
- Vehicle:
- physiological saline
- Concentration / amount:
- 1% for the intradermal induction
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vasiline
- Concentration / amount:
- 6.25% for the dermal induction
- Adequacy of induction:
- highest concentration used causing mild-to-moderate skin irritation and well-tolerated systemically
Challenge
- No.:
- #1
- Route:
- epicutaneous, occlusive
- Vehicle:
- other: vasiline
- Concentration / amount:
- a concentration of 3% for the challenge application
- Adequacy of challenge:
- highest non-irritant concentration
- No. of animals per dose:
- Number of animals in the test group: 10
Number of animals in the negative-control group: 5
Number of animals in the positive control group: 5
Number of animals in the dose range finding study: 8 - Details on study design:
- Based on the results of this preliminary test the following concentrations were chosen for the main test:
a concentration of 1% for the intradermal induction
a concentration of 6.25% for the dermal induction
a concentration of 3% for the challenge application - Challenge controls:
- For the intradermal injection (induction - first stage), 0.2 g of the positive control were suspended in cottonseed oil to gain a final volume of 10 mL of a 2% solution (w/v).
For the topical application (induction – second stage), 2.5 g of the positive control were suspended in vaseline to gain a final volume of 10 g of a 25% suspension (w/w).
For the topical application (challenge), 3 g of the positive control were suspended in vaseline to gain a final volume of 20 g of a 15% suspension (w/w). - Positive control substance(s):
- yes
- Remarks:
- 2-Mercaptobenzothiazole
Results and discussion
In vivo (non-LLNA)
Resultsopen allclose all
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 4
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 3 %. No with. + reactions: 4.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- test chemical
- Dose level:
- 3 %
- No. with + reactions:
- 1
- Total no. in group:
- 10
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 3 %. No with. + reactions: 1.0. Total no. in groups: 10.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: negative control. Dose level: 3 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- negative control
- Dose level:
- 3 %
- No. with + reactions:
- 0
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: negative control. Dose level: 3 %. No with. + reactions: 0.0. Total no. in groups: 5.0.
- Key result
- Reading:
- 1st reading
- Hours after challenge:
- 24
- Group:
- positive control
- Dose level:
- 3 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 24.0. Group: positive control. Dose level: 3 %. No with. + reactions: 5.0. Total no. in groups: 5.0.
- Key result
- Reading:
- 2nd reading
- Hours after challenge:
- 48
- Group:
- positive control
- Dose level:
- 3 %
- No. with + reactions:
- 5
- Total no. in group:
- 5
- Remarks on result:
- other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: positive control. Dose level: 3 %. No with. + reactions: 5.0. Total no. in groups: 5.0.
Any other information on results incl. tables
1. Induction: First Stage, Intradermal Injection
Test Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: a 1% concentration of the test item in physiological saline 0.9% NaCl
Injection 3: a 1% concentration of the test item formulated in a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Negative Control Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 100% physiological saline 0.9% NaCl
Injection 3: a 50% (v/v) formulation of physiological saline 0.9% NaCl in a 1:1 (v/v)
mixture FCA/physiological saline 0.9% NaCl
Injections 1 and 2 were given close to each other and nearest to the head, while
injection 3 was given toward the caudal part of the test area.
Positive Control Group: Day 0
Injection 1: a 1:1 mixture (v/v) FCA/physiological saline 0.9% NaCl
Injection 2: 2% mercaptobenzothiazole in cottonseed oil
Injection 3: a 50% w/v formulation of mercaptobenzothiazole in a 1:1 (v/v)
mixture FCA/physiological saline 0.9% NaCl
2. Induction: Second Stage, Topical Application
Test Group and Control Groups: Day 6
Approximately twenty-four hours before the topical application the test area was
close-clipped.
Test Group: Day 7
The test item was suspended in vaseline at a concentration of 6.25%. A patch was fully loaded with 0.5 g of the prepared test item. Then it was applied to the test area and held in contact with the help of an occlusive dressing for 48 hours.
Negative Control Group: Day 7
A patch was fully loaded with 0.5 g of vaseline. Then it was applied to the test area and held in contact with the help of an occlusive dressing for 48 hours.
Positive Control Group: Day 7
A patch was fully loaded with 2.0 mL of 2-Mercaptobenzothiazol at a concentration of 25% (vehicle: vaseline), applied to the test area and held in contact by an occlusive dressing for 48 hours.
3. Challenge: Topical Application
The flanks of treated and control animals were cleared of hair by close-clipping.
Test Group and Negative Control Group: Day 20
The test item was suspended with vaseline at a concentration of 3%. A patch loaded with 0.5 g of the prepared test item was applied to the left flank of the animals and a patch loaded with 0.5 g of vaseline to the right flank (intraspecific control). The patches
were held in contact with the help of an occlusive dressing for 24 hours.
Positive Control Group: Day 20
A patch loaded with 2.0 mL of 2-Mercaptobenzothiazol at a concentration of 15% was applied to the left flank of the animals and, a patch loaded with 0.5 g of vaseline to the right flank (intraspecific control), respectively. The patches were held in contact by an occlusive dressing for 24 hours. The application area was not rinsed.
Approximately 24 hours after removing the patch, the challenge area was cleared of hair by the use of a depilatory cream. Approximately 24 and 48 hours after removing the patch the skin reaction was observed and recorded. Additionally all animals were observed for signs of toxicity at least once daily during the test period.
Applicant's summary and conclusion
- Interpretation of results:
- Category 1B (indication of skin sensitising potential) based on GHS criteria
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- Under the conditions of the present study it can be stated that the test item caused reactions identified as sensitisation at the tested concentration.
According to the EC criteria for classification and labelling requirements for dangerous substances and preparations (Guidelines in Commission Directive 2001/59/EC) labelling is necessary, as the percentage of sensitised animals was greater than 30%.
According to Commission Regulation (EU) No 286/2011 as well as GHS (Globally Harmonized Classification System) the test item has obligatory labelling requirement for skin sensitisation and is classified into Category 1B. - Executive summary:
Introduction:
The test for sensitisation is performed on the guinea pig. It has been the animal of choice for predictive sensitisation tests for surfactants, e.g. alkylsulfates, alkylethersulfates. The assessment of the test item to produce skin sensitisation is achieved through multiple exposure under standardised conditions.
Method:
For the intradermal injection (induction - first stage), 0.1 g of the test item were dissolved in physiological saline 0.9% NaCl to gain a final volume of 10 mL of a 1% solution (w/v). For the topical application (induction – second stage), 0.625 g of the test item were suspended in vaseline to gain a final volume of 10 g of a 6.25% suspension (w/w). For the topical application (challenge), 0.3 g of the test item were suspended in vaseline to gain a final volume of 10 g of a 3% suspension (w/w).
2-Mercaptobenzothiazole was used as positive control.
Conclusion:
Under the conditions of the present study it can be stated that the test item caused reactions identified as sensitisation at the tested concentration.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.